Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a 6-12 month period without a clear cause, oftentimes presents a diagnostic challenge in clinical practice. This article seeks to provide a comprehensive approach to the assessment and management of this condition.
The etiology of UWL is vast, ranging from malignancies, gastrointestinal disorders, endocrine abnormalities, psychiatric conditions, to infectious diseases. Malignancies, especially gastrointestinal and lung cancers, have been identified as the most common cause. However, no cause is found in up to 25% of cases, even after extensive evaluation.
A thorough history and physical examination should be the initial step in the evaluation of UWL. This should be followed by basic laboratory tests and imaging studies based on the suspected underlying cause. If these initial investigations are inconclusive, more specialized tests and referrals may be necessary. It is also crucial to consider the patient's age, as the risk of malignancy increases with age.
The management of UWL primarily involves treating the underlying cause. In cases where no cause is identified, the focus should be on nutritional support and close monitoring of the patient. Behavioral interventions may also be beneficial. In addition, patients should be reassured that a significant proportion of UWL cases remain idiopathic and are not associated with serious illness.
In conclusion, UWL is a complex condition that requires a systematic and patient-centered approach. While it can be a sign of serious underlying disease, it is important to remember that a significant proportion of cases remain unexplained. The primary goal should be to provide supportive care and reassurance to the patient while continuing to monitor for potential causes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation